Urinary bisphenol A and obesity: NHANES 2003-2006

Environmental Research

Volumn 111, Issue 6, 2011, Pages 825-830

  Carwile, Jenny L ^a   Michels, Karin B ^a,b,c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Bisphenol A (BPA); Endocrine disruptors; Human; NHANES; Obesity

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL;

ADULT; BODY MASS; CONCENTRATION (COMPOSITION); ENDOCRINE DISRUPTOR; FOOD PROCESSING; HEALTH RISK; HEALTH SURVEY; OBESITY; PHENOL; POLLUTION EXPOSURE; RODENT; URINE; WEIGHT;

ABDOMINAL OBESITY; ADULT; AGED; ARTICLE; BODY MASS; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; GEOMETRY; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; URINALYSIS; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; OBESITY; PHENOLS; UNITED STATES; YOUNG ADULT;

UNITED STATES;

ANIMALIA; RODENTIA;

EID: 79960639578     PISSN: 00139351     EISSN: 10960953     Source Type: Journal    
DOI: 10.1016/j.envres.2011.05.014     Document Type: Article

References (46)

1. Alonso-Magdalena P., et al. The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ. Health Perspect. 2006, 114:106-112.
2. Barr D.B., et al. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ. Health Perspect. 2005, 113:192-200.
3. Ben-Jonathan N., et al. Effects of bisphenol A on adipokine release from human adipose tissue: implications for the metabolic syndrome. Mol. Cell. Endocrinol. 2009, 304:49-54.
4. Calafat A.M., et al. Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ. Health Perspect. 2008, 116:39-44.
5. Centers for Disease Control and Prevention (CDC), 2004a. National Health and Nutrition Examination Survey Data 2003-04. Hyattsville, MD.
6. Centers for Disease Control and Prevention (CDC), 2004b. NHANES 2003-2004 Laboratory Procedure Manual. Available: (accessed 30 March 2010). http://www.cdc.gov/nchs/data/nhanes/nhanes_03_04/l24eph_c_met_phenols.pdf.
7. Centers for Disease Control and Prevention (CDC), 2006a. National Health and Nutrition Examination Survey Data 2005-06. Hyattsville, MD.
8. Centers for Disease Control and Prevention (CDC), 2006b. NHANES 2005-2006 Laboratory Procedure Manual. Available: (accessed 30 March 2010). http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/eph_d_met_phenols_parabens.pdf.
9. Clasey J.L., et al. The use of anthropometric and dual-energy X-ray absorptiometry (DXA) measures to estimate total abdominal and abdominal visceral fat in men and women. Obes. Res. 1999, 7:256-264.
10. Fernandez M.F., et al. Bisphenol-A and chlorinated derivatives in adipose tissue of women. Reprod. Toxicol. 2007, 24:259-264.
11. Galloway T., et al. Daily bisphenol A excretion and associations with sex hormone concentrations: results from the InCHIANTI adult population study. Environ. Health Perspect. 2010, 118:1603-1608.
12. Ginsberg G., Rice D.C. Does rapid metabolism ensure negligible risk from bisphenol A?. Environ. Health Perspect. 2009, 117:1639-1643.
13. Heindel J.J. Endocrine disruptors and the obesity epidemic. Toxicol. Sci. 2003, 76:247-249.
14. Howdeshell K.L., et al. Exposure to bisphenol A advances puberty. Nature 1999, 401:763-764.
15. Hu F.B. Obesity Epidemiology 2008, Oxford University Press, New York.
16. Hu F.B., et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N. Engl. J. Med. 2001, 345:790-797.
17. Hugo E.R., et al. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ. Health Perspect. 2008, 116:1642-1647.
18. Kang J.H., et al. Human exposure to bisphenol A. Toxicology 2006, 226:79-89.
19. Lang I.A., et al. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. Jama 2008, 300:1303-1310.
20. Mahalingaiah S., et al. Temporal variability and predictors of urinary bisphenol A concentrations in men and women. Environ. Health Perspect. 2008, 116:173-178.
21. Malik S., et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004, 110:1245-1250.
22. Malik V.S., et al. Intake of sugar-sweetened beverages and weight gain: a systematic review. Am. J. Clin. Nutr. 2006, 84:274-288.
23. Masuno H., et al. Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol. Sci. 2005, 84:319-327.
24. Masuno H., et al. Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J. Lipid Res. 2002, 43:676-684.
25. Melzer D., et al. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One 2010, 5:e8673.
26. Miyawaki J., et al. Perinatal and postnatal exposure to bisphenol a increases adipose tissue mass and serum cholesterol level in mice. J. Atheroscler. Thromb. 2007, 14:245-252.
27. Newbold R.R., et al. Long-term adverse effects of neonatal exposure to bisphenol A on the murine female reproductive tract. Reprod. Toxicol. 2007, 24:253-258.
28. Newbold R.R., et al. Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod. Toxicol. 2007, 23:290-296.
29. Patisaul H.B., Bateman H.L. Neonatal exposure to endocrine active compounds or an ERbeta agonist increases adult anxiety and aggression in gonadally intact male rats. Horm. Behav. 2008, 53:580-588.
30. Rubin B.S., et al. Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma LH levels. Environ. Health Perspect. 2001, 109:675-680.
31. Rubin B.S., Soto A.M. Bisphenol A: perinatal exposure and body weight. Mol. Cell Endocrinol. 2009, 304:55-62.
32. Ryan K.K., et al. Perinatal exposure to bisphenol-a and the development of metabolic syndrome in CD-1 mice. Endocrinology 2010, 151:2603-2612.
33. Sakurai K., et al. Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br. J. Pharmacol. 2004, 141:209-214.
34. Seidlova-Wuttke D., et al. Effects of bisphenol-A (BPA), dibutylphtalate (DBP), benzophenone-2 (BP2), procymidone (Proc), and linurone (Lin) on fat tissue, a variety of hormones and metabolic parameters: a 3 months comparison with effects of estradiol (E2) in ovariectomized (ovx) rats. Toxicology 2005, 213:13-24.
35. Somm E., et al. Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ. Health Perspect. 2009, 117:1549-1555.
36. Stahlhut R.W., et al. Bisphenol A data in NHANES suggest longer than expected half-life, substantial nonfood exposure, or both. Environ. Health Perspect. 2009, 117:784-789.
37. Takeuchi T., et al. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr. J. 2004, 51:165-169.
38. Vandenberg L.N., et al. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect. 2010, 118:1055-1070.
39. Vandenberg L.N., et al. Human exposure to bisphenol A (BPA). Reprod. Toxicol. 2007, 24:139-177.
40. Vandenberg L.N., et al. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 2009, 30:75-95.
41. Volkel W., et al. Quantitation of bisphenol A and bisphenol A glucuronide in biological samples by high performance liquid chromatography-tandem mass spectrometry. Drug Metab. Dispos. 2005, 33:1748-1757.
42. Volkel W., et al. Metabolism and kinetics of bisphenol a in humans at low doses following oral administration. Chem. Res. Toxicol. 2002, 15:1281-1287.
43. Wang Y., et al. Will all Americans become overweight or obese? estimating the progression and cost of the US obesity epidemic. Obesity (Silver Spring) 2008, 16:2323-2330.
44. Willett W. Nutritional Epidemiology 1998, Oxford University Press, New York (NY).
45. Wilson P.W., et al. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation 2005, 112:3066-3072.
46. Wilson P.W., et al. Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch. Intern. Med. 2002, 162:1867-1872.